
|Articles|September 1, 2010
Debate box
As the Health Information Technology Policy Committee (HITPC) prepares the stage two definition of “meaningful use” of EHRs, there is ongoing debate over the perceived long-term benefits versus the immediate expenses-both in terms of money and time. This week we discuss the current status of EHR implementation and incentives.
Advertisement
As the Health Information Technology Policy Committee
(HITPC) prepares the stage two definition of “meaningful use”
of EHRs, there is ongoing debate over the perceived long-term
benefits versus the immediate expenses-both in terms of
money and time. This week we discuss the current status
of
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Gastric Cancers
2
FDA Grants Priority Review to Dostarlimab in dMMR/MSI-H Rectal Cancer
3
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer
4
Teclistamab Combo Earns EU Approval in Relapsed/Refractory Multiple Myeloma
5






























































